Wan-Shon Lo

Shon has represented companies in patent, trademark and copyright infringement, and trade secret misappropriation actions. Shon’s advocacy on behalf of generic and branded pharmaceutical companies and biotech companies has involved products including Dupixent®, Repatha®, Praluent®, Sernivo®, Toviaz®, Nuvigil®, Clindesse®, Rapaflo®, Doribax®, Remodulin®, Taclonex®, Dovonex®, MetroGel®, OrthoTriCyclen Lo®, and others. Shon particularly enjoys advising clients about the patent, regulatory, and antitrust issues that arise in the context of pharmaceutical product development and subsequent litigation.

Shon began conducting research as an undergraduate and continued as a research technician and graduate student in various laboratories in the fields of molecular, cellular, and developmental biology and neurobiology at MIT, Stanford and the University of Chicago. In the course of her prior career as a scientist, Shon co-authored several scientific articles, including an article published in Science magazine.

Additionally, Shon has cultivated a pro bono practice focused on immigration law, and has also assisted authors, artists, and nonprofit companies obtain and protect their intellectual property rights. She is conversant in Mandarin.

• Represented market-leading orthopaedic device manufacturer in trade secret misappropriation and unfair competition-based Investigations before the International Trade Commission.
• Lead counsel for defendant in district court litigations concerning Sernivo® in Promius Pharma LLC v. Perrigo et al. (E.D. Tex.) and Promius Pharma LLC v. Taro Pharmaceuticals Inc. (S.D.N.Y).  
• Co-lead counsel for a large, cross-practice team defending an academic medial hospital and physician-researcher against patent infringement, breach of contract, unjust enrichment, and tortious interference claims in district court litigation concerning cancer immunotherapies in Immunomedics, Inc. v. Roger Williams Medical Center, et al. (D.N.J.).
• Co-lead counsel for plaintiff in a copyright infringement action involving unauthorized distribution of reproductions of plaintiff’s portraits in Jesus Muhammad-Ali v. Final Call, Inc. (N.D. Ill.). 
• Represented plaintiff in district court litigation concerning a blockbuster monoclonal antibody for treatment of allergic diseases in Immunex Corp. v. Sanofi et al. (C.D. Cal.). 
• Represented the defendant in district court litigation concerning pool floats in SwimWays Corp. & Kelsyus LLC v. Bestway (USA), Inc. (E.D. Va.). 
• Led team representing the plaintiff in district court litigation concerning Clindesse® in Elan Pharma Int’l Ltd. v. Actavis Labs. UT, Inc. (D. Del.). 
• Represented the defendant in district court litigation and trial concerning Toviaz® in Pfizer, Inc. & UCB Pharma v. Alkem, Inc., et al. (D. Del.). 
• Represented the defendant in district court litigation and in an appeal to the US Circuit Court of Appeals for the Federal Circuit concerning Nuvigil® in In re Armodafinil (D. Del.). 
• Represented the defendant in district court litigations concerning Dovonex® and Taclonex® in Leo Pharma A/S v. Tolmar, Inc. (D. Del.). 
• Represented the defendant in district court litigation concerning MetroGel® in Galderma Labs, LP v. Tolmar, Inc. (N.D. Texas).
• Represented a national chain of photo studios in trademark infringement litigation in Picture Me Press v. CPI Corp. (N.D. Ohio).
• Represented the defendant in patent infringement and breach of contract litigation in Spoilage Cutter Co. v. World Kitchen (N.D. Ill.).